Navigation Links
Cardica to Host Investor Briefing on 'Revolutionizing Revascularization'

- Event to Be Webcast June 12 at 5:15 p.m. Eastern Time - - PAS-Port(R) System Clinical Data To Be Presented During Late Breaking News Session of International Society for Minimally Invasive Cardiothoracic

Surgery Annual Meeting -

REDWOOD CITY, Calif., June 9 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that it will webcast an investor briefing on the topic of "Revolutionizing Revascularization" on Thursday, June 12, at 5:15 p.m. Eastern Time in Boston. The event will feature a panel of renowned cardiovascular surgeons who will discuss how surgeons are integrating new techniques to improve coronary artery bypass graft (CABG) procedures, including the use of Cardica's C-Port(R) Distal Anastomosis Systems, which are designed to allow surgeons to automate the attachment of blood vessel grafts during CABG procedures, replacing traditional hand-sewn sutures.

The Company also announced that data from the 220-patient prospective, randomized pivotal clinical trial of its PAS-Port(R) Proximal Anastomosis System will be presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) in Boston. The presentation, entitled "The Cardica PAS-Port Proximal Anastomotic Connector Device: First Report of the Results of the FDA Trial," will be given during the Late Breaking News session on Thursday, June 12, at 1:15 p.m. Eastern Time by principal study investigator John D. Puskas, M.D., chief of cardiac surgery at Emory Crawford Long Hospital in Atlanta. As previously announced, the trial, which compared graft vessel connections made using the PAS-Port system to conventional hand-sewn sutures during CABG procedures, achieved all of its primary and secondary endpoints. Based on the positive trial data, Cardica submitted a 510(k) premarket notification in April to the U.S. Food and Drug Administration for the PAS-Port system.
Panelists for the investor event will include:

-- Husam H. Balkhy, M.D., chairman of cardiothoracic surgery at The

Wisconsin Heart Hospital and clinical assistant professor of surgery at

the Medical College of Wisconsin. He is a well-known advocate of

minimally-invasive cardiac surgery and has the largest experience in

the United States with distal anastomotic devices in coronary artery


-- Robert S. Poston, M.D., chief of cardiac surgery at Boston Medical

Center. Previously, he was an associate professor of surgery at the

University of Maryland where he focused his activities in the field of

off-pump and minimally-invasive/robotic CABG. His research into

minimally-invasive CABG and the hybrid procedure was recognized in 2005

by the Daily Record magazine as an "Innovation of the Year."

-- Sudhir Srivastava, M.D., director of robotic and minimally-invasive

cardiac surgery at the University of Chicago Medical Center. He

pioneered both the da Vinci revascularization and port-only coronary

artery bypass surgical methods and has performed more of these

procedures than any other surgeon in the world.

Webcast Details

The event will be webcast live on Thursday, June 12, at 5:15 p.m. Eastern Time. To access the live and subsequently archived webcast of the discussion, go to the Investor Relations section of Cardica's website at Please connect to the website at least 15 minutes prior to the webcast to allow for any necessary software downloads.

About Cardica

Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has submitted a 510(k) premarket notification for clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures.

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
2. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
3. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
4. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
5. BD to Present at Investor Healthcare Conferences
6. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
7. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
8. CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
9. Hospital to Hold MRSA Briefing for Media and Community Leaders
10. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
11. CPR Data Debriefing by Hospital Responders Improves CPR Performance and Increases Initial Survival Rate Following Cardiac Arrest
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... set to go online. The potential to save costs, ... vast and far from fully exploited as yet. Here, ... health records, either via mobile tablet or directly at ... --> ) -->      ...
(Date:11/27/2015)... Niederlande, November 27, 2015 ... bei fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   Clinical Cancer Research ... Clinical Cancer Research vom 6. November ...
(Date:11/27/2015)... , Nov. 27, 2015  Lannett Company, Inc. ... has completed the acquisition of Kremers Urban Pharmaceuticals ... of global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... Lannett has acquired KU from UCB for total ... adjustments, including a customary working capital adjustment, a ...
Breaking Medicine Technology:
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from ... dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , ... prescription medications. In doing so, it could help to prevent potential overdose situations. ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... filthy the toilets were," said an inventor from Hillside, N.J. "Many people catch ... seat cover so that individuals will always be protected from germs." , He ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
(Date:11/27/2015)... ... , ... The print component of “Supporting Our Caregivers” is ... York, Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an ... social media strategy and across a network of top news sites and partner ...
Breaking Medicine News(10 mins):